COMPOSITION FOR INHIBITING CELLULAR SENESCENCE CONTAINING MELANDRIUM FIRMUM ROHRBACH EXTRACT OR BORNESITOL SEPARATED FROM SAME AS ACTIVE INGREDIENT

摘要

The present invention relates to a composition for inhibiting cellular senescence containing a Melandrium firmum Rohrbach extract or (-)-bornesitol separated from same as an active ingredient, the provided pharmaceutical composition for inhibiting cellular senescence being derived from Adriamycin. The present invention inhibits the process of cellular senescence of fibroblasts or umbilical vein endothelial cells, and thus may be usefully employed for treating diseases related to senescence, for example, skin aging, rheumatoid arthritis, osteoarthritis, hepatitis, chronic skin damage tissue, arteriosclerosis, prostatic hyperplasia, and liver cancer, etc. Further, the present invention is expected to be used for developing anti-aging functional food, anti-vascular aging drugs, and cosmetics which may inhibit cellular senescence.